Diabetic nephropathy is a complication of diabetes that affects the kidneys. Hyperkalemia refers to high levels of potassium in the blood. Damage to the kidneys can result in hyperkalemia. Diabetic ...

Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers are used commonly in clinical practice to treat hypertension and decrease cardiovascular events in high-risk patients.

Hyperkalemia is a condition where potassium levels in the blood are abnormally high. Anyone can develop it, but certain people, such as those with kidney dysfunction, have an increased risk. Having ...

Hyperkalemia, or high potassium, can result from kidney disease, certain medications, alcohol use, and other health conditions. In some instances, it may not present any symptoms. Diagnosis involves a ...

Hyperkalemia is common among elderly patients and is associated with an increase in morbidity and mortality. Patients at highest risk for developing hyperkalemia are those with chronic kidney disease ...

Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...

Searching for effective treatment options for 'Hyperkalemia symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

Hyperkalemia occurs when blood potassium levels rise above 5.0 mmol/L, most commonly due to chronic kidney disease (CKD). This can affect heart and breathing muscles, potentially leading to muscle ...

A new risk model may help identify which patients with chronic kidney disease (CKD) and diabetes are more likely to develop hyperkalemia, granting physicians more confidence in prescribing medications ...

Hyperkalemia is an abnormally high level of potassium in the blood. The normal level of serum potassium (potassium in the fluid portion of the blood) is 3.5 to 5.0 mmol/l. When serum potassium is ...

MINNEAPOLIS — A reduced risk for death may balance out concerns about hyperkalemia when treating heart failure with renin-angiotensin system (RAS) inhibitors and mineralocorticoid receptor antagonists ...